000 01578 a2200445 4500
005 20250514215021.0
264 0 _c20050607
008 200506s 0 0 eng d
022 _a0006-4971
024 7 _a10.1182/blood-2004-11-4435
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aChen, Hsiu-Hui
245 0 0 _aFusion proteins comprising annexin V and Kunitz protease inhibitors are highly potent thrombogenic site-directed anticoagulants.
_h[electronic resource]
260 _bBlood
_cMay 2005
300 _a3902-9 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAmyloid beta-Peptides
_xchemistry
650 0 4 _aAnimals
650 0 4 _aAnnexin A5
_xgenetics
650 0 4 _aAnticoagulants
_xchemistry
650 0 4 _aBlood Coagulation
_xdrug effects
650 0 4 _aCattle
650 0 4 _aFactor Xa
_xmetabolism
650 0 4 _aHumans
650 0 4 _aMice
650 0 4 _aModels, Animal
650 0 4 _aProtease Inhibitors
_xchemistry
650 0 4 _aProtein Structure, Tertiary
650 0 4 _aRecombinant Fusion Proteins
_xgenetics
650 0 4 _aSwine
650 0 4 _aThrombosis
_xmetabolism
650 0 4 _aTime Factors
650 0 4 _aTrypsin
_xmetabolism
700 1 _aVicente, Cristina P
700 1 _aHe, Li
700 1 _aTollefsen, Douglas M
700 1 _aWun, Tze-Chein
773 0 _tBlood
_gvol. 105
_gno. 10
_gp. 3902-9
856 4 0 _uhttps://doi.org/10.1182/blood-2004-11-4435
_zAvailable from publisher's website
999 _c15355417
_d15355417